HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xu Cui Selected Research

Borates

3/2014A novel injectable borate bioactive glass cement for local delivery of vancomycin to cure osteomyelitis and regenerate bone.
1/2014A novel injectable borate bioactive glass cement as an antibiotic delivery vehicle for treating osteomyelitis.
10/2013In vitro bioactivity, cytocompatibility, and antibiotic release profile of gentamicin sulfate-loaded borate bioactive glass/chitosan composites.
7/2013Gentamicin-loaded borate bioactive glass eradicates osteomyelitis due to Escherichia coli in a rabbit model.
6/2012[Injectable borate glass/chitosan composite as drug carrier for treatment of chronic osteomyelitis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xu Cui Research Topics

Disease

29Stroke (Strokes)
01/2022 - 08/2006
17Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
06/2020 - 08/2006
8Infections
01/2019 - 02/2012
8Pain (Aches)
12/2015 - 08/2005
6Hemorrhage
05/2022 - 04/2020
5Osteoporosis
01/2022 - 11/2016
5Spinal Tuberculosis (Pott's Disease)
11/2016 - 02/2012
4Neoplasms (Cancer)
06/2022 - 06/2014
4Wounds and Injuries (Trauma)
05/2022 - 12/2015
4Inflammation (Inflammations)
05/2022 - 01/2013
4Osteoarthritis
01/2022 - 07/2014
4Osteomyelitis
03/2014 - 06/2012
4Cognitive Dysfunction
08/2006 - 10/2003
3Hypoxia (Hypoxemia)
06/2021 - 01/2014
3Infarction (Infarctions)
01/2017 - 01/2013
2Burns
01/2022 - 09/2020
2Neuroinflammatory Diseases
01/2022 - 01/2016
2Diabetic Foot
11/2021 - 10/2020
2Surgical Wound Infection
06/2020 - 01/2020
2Esophageal Atresia
04/2020 - 03/2020
2Leukemia
02/2013 - 01/2007
2Congenital Abnormalities (Deformity)
05/2012 - 02/2012
2Memory Disorders (Memory Loss)
08/2006 - 06/2006
1Embolism (Embolus)
05/2022
1Hypersensitivity (Allergy)
05/2022
1Anaphylaxis (Anaphylactic Shock)
05/2022
1type 2C Congenital disorder of glycosylation
05/2022
1Carcinoma (Carcinomatosis)
04/2022

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2011
5ChitosanIBA
05/2022 - 06/2012
5VancomycinFDA LinkGeneric
06/2020 - 06/2012
5Phosphates (Orthophosphate)IBA
01/2016 - 11/2007
5BoratesIBA
03/2014 - 06/2012
5Simvastatin (Zocor)FDA LinkGeneric
01/2012 - 01/2009
4Peptides (Polypeptides)IBA
05/2022 - 01/2016
4Pharmaceutical PreparationsIBA
01/2022 - 07/2010
4Oxygen (Dioxygen)IBA
11/2021 - 02/2011
4CholesterolIBA
01/2021 - 07/2010
4Liver X ReceptorsIBA
01/2017 - 01/2010
4Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2013 - 09/2010
4Niacin (Nicotinic Acid)FDA LinkGeneric
09/2010 - 07/2007
4Galactose (Galactopyranose)FDA LinkGeneric
06/2007 - 10/2003
3Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2022 - 01/2016
3Neuroprotective AgentsIBA
01/2022 - 01/2013
3MicroRNAs (MicroRNA)IBA
01/2022 - 11/2019
3Malondialdehyde (Propanedial)IBA
06/2021 - 06/2006
3Apolipoproteins E (ApoE)IBA
06/2020 - 01/2017
3AngiopoietinsIBA
01/2019 - 08/2006
3Therapeutic UsesIBA
01/2018 - 10/2009
3Anti-Bacterial Agents (Antibiotics)IBA
03/2014 - 07/2013
3Angiopoietin-1IBA
01/2013 - 01/2009
32,2'- (hydroxynitrosohydrazono)bis- ethanamineIBA
01/2009 - 08/2006
3Nitric Oxide DonorsIBA
01/2009 - 08/2006
3Thioctic Acid (Lipoic Acid)IBA
06/2007 - 06/2006
2IonsIBA
06/2022 - 06/2021
2CytokinesIBA
05/2022 - 06/2021
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2022 - 01/2016
2RNA (Ribonucleic Acid)IBA
11/2021 - 09/2020
2Streptozocin (Streptozotocin)FDA Link
06/2021 - 12/2011
2EnzymesIBA
04/2021 - 09/2012
29- (benzoyloxy)- 2- (3- furanyl)dodecahydro- 6a,10b- dimethyl- 4,10- dioxo- 2H- naphtho(2,1- c)pyran- 7- carboxylic acid methyl esterIBA
04/2021 - 01/2017
2Apolipoprotein E2IBA
06/2020 - 10/2018
2Glucose (Dextrose)FDA LinkGeneric
01/2019 - 02/2011
2GW 3965IBA
01/2017 - 01/2013
2cytidylyl-(3'-5')-cytidine (CpC)IBA
01/2017 - 11/2016
2HDL LipoproteinsIBA
01/2016 - 11/2008
2Calcium Sulfate (Alabaster)IBA
03/2014 - 01/2014
2Gentamicins (Gentamicin)FDA LinkGeneric
10/2013 - 07/2013
2SynaptophysinIBA
01/2013 - 09/2010
2OccludinIBA
01/2013 - 08/2006
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2013 - 10/2007
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2013 - 07/2009
2Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
12/2011 - 07/2007
2SilverIBA
02/2011 - 09/2010
2Cholinergic ReceptorsIBA
09/2004 - 10/2003
1Hydroxyl RadicalIBA
06/2022
1Bone SubstitutesIBA
06/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2022
1Hemostatics (Antihemorrhagics)IBA
05/2022
1FibrinIBA
05/2022
1AlginatesIBA
05/2022
1CollagenIBA
05/2022
1Immunoglobulin E (IgE)IBA
05/2022
1MeglumineFDA Link
05/2022
1Histamine (Histamine Dihydrochloride)FDA Link
05/2022
1Gadolinium DTPA (Magnevist)FDA Link
05/2022
1Messenger RNA (mRNA)IBA
05/2022
1Tryptases (Tryptase)IBA
05/2022
1SaltsIBA
04/2022

Therapy/Procedure

8Therapeutics
06/2022 - 02/2007
4Operative Surgical Procedures
08/2020 - 02/2012
4Drug Therapy (Chemotherapy)
01/2018 - 03/2013
4Decompression
11/2016 - 02/2012
3Artificial Respiration (Mechanical Ventilation)
04/2020 - 03/2020
3Injections
03/2014 - 06/2012
3Hip Replacement Arthroplasty (Total Hip Replacement)
05/2006 - 08/2005
2Intravenous Injections
05/2022 - 01/2014
2Analgesia
03/2022 - 12/2015
2Thoracoscopes
04/2020 - 03/2020
2Critical Care (Surgical Intensive Care)
04/2020 - 03/2020